Elevated Rheumatoid Factor Article

What is Rheumatoid Arthritis And How To Identify Its Symptoms
By Jack Harmon

Rheumatoid arthritis (RA) can be defined as a multisystem chronic disease of unknown origin. There is an array of systemic expression; the main distinguishing feature of rheumatoid arthritis is chronic inflammatory synovitis, typically symmetrically involving peripheral joints.

The likely influence of inflammation of the synovium leading to damage of the articular cartilage and erosion of the involving bones and consequent changes in the integrity of the joint is the characteristic of the disease. RA also involves the tissues around the joint as well as different organs in our body.

Characteristically, Rheumatoid arthritis is an autoimmune disorder, which occurs when the body's own defense mechanism wrongly interprets some bodily character and mistakenly attacks them.

The immune system is a multifaceted association of different protective cells and antibodies programmed normally to 'seek and destroy' the intruders into our body. The main role playing of the immune system occurs when an infective agent invades our system.

Patients having deranged immunity or autoimmune disorder produce antibodies (some proteins that have a killer potentiality towards intruders) in the blood that targets their own body parts, leading to inflammation. As rheumatoid arthritis can affect numerous other organs in our body, it is referred as a systemic disease.

The word "Rheumatoid" is coined from the Greek word "Rheumatos" which means 'Flowing' and the suffix "oid" refers to 'resembling'. The word "Arthritis" means 'inflammation of a joint'. So, together they mean 'inflammation of a joint that is flowing in nature'. In spite of its harsh potential, the course of the disease can vary a lot.

Some patients can experience a mere oligoarticular ailment (involving a single joint) of short duration with minimal or no joint damage, while others may suffer from a persistent progressive polyarthritis with striking functional impairment.

Rheumatoid arthritis has very common symptoms and according to a survey, it has affected more than two million people in the United States.

The disease is almost three times more common in women than in men and affects people of all races uniformly. The onset of the disease can be at any age, but the usual point of time is after forty years of age. Being a genetically determined disease,

Rheumatoid arthritis can affect multiple members in the same family. As for example, severe RA is noticed in approximately four times the usual rate among the first degree relatives of persons suffering from the disease in conjunction with presence of autoantibody - the Rheumatic factor- more than 10% of patients with RA will have an affected first degree relative.

In addition, monozygotic twins are at least four times more likely to develop RA than dizygotic twins. This is to be noted that, the highest risk of association id noted in twins who possess two HLA-DRB1 alleles (a type of genes) which is identified to be closely linked with RA. Genetic predisposing factors do not entirely account for the occurrence of RA, pointing towards some other factors. Environmental factors have a role playing action in the development of RA.

This is highlighted by epidemiological studies conducted in AFRICA, that indicated the role of urbanization and climate have a major impact over the occurrence and severity of RA.

To get relief from rheumatoid arthritis pain visit rheumatoid arthritis pain relief for more information.

Recommended Products



____________________


Arthritis image 1

Arthritis image 2

Related Elevated Rheumatoid Factor Videos


Elevated Rheumatoid Factor News


Abbott sues Bayer in patent fight - Chicago Daily Herald

7 Jan 2009 at 10:35am 

Abbott sues Bayer in patent fight
Chicago Daily Herald, IL - 9 hours ago
24 lawsuit, claiming that the drug violates its patent issued in 1997 for antibodies against tumor necrosis factor, or TNF, an immune cell protein that is ...


Read more...


European Market Update: Central Bankers and Government officials ... - Fxtrad...

7 Jan 2009 at 5:37am 

European Market Update: Central Bankers and Government officials ...
Fxtraders.eu, Poland - 14 hours ago
UK] Received European product approval for Lodotra in the treatment of rheumatoid arthritis and associated morning stiffness || Bayer Schering [BAY. ...


Read more...


Skyepharma PLC announces European Product Approval - CNNMoney.com

7 Jan 2009 at 1:16am 

Skyepharma PLC announces European Product Approval
CNNMoney.com - 19 hours ago
This night-time release formulation is especially suited to the treatment of early morning stiffness, which is associated with rheumatoid arthritis, ...


Read more...


UCB Receives Complete Response Letter From US FDA for Use of ... - MSNBC

6 Jan 2009 at 3:58pm 

UCB Receives Complete Response Letter From US FDA for Use of ...
MSNBC - Jan 6, 2009
"UCB is confident and committed to making Cimzia® available to people living with moderate to severe rheumatoid arthritis and other inflammatory conditions ...
UCB stock down as FDA asks for more Cimzia data Pharma Times
UCB falls sharply on Cimzia setback Forbes
all 20 news articles


Read more...


Huge Discrepancy in RA Treatment in Dubai: Expert - Khaleej Times

6 Jan 2009 at 2:14pm 

Huge Discrepancy in RA Treatment in Dubai: Expert
Khaleej Times, United Arab Emirates - Jan 6, 2009
... individuals by using medical examination, medical history, symptoms and laboratory tests (such as a test for the presence of rheumatoid factor). ...


Read more...


Axis-Shield develops anti-CCP rheumatoid arthritis test for Abbott ... - Proa...

6 Jan 2009 at 7:20am 

Proactive Investors UK

Axis-Shield develops anti-CCP rheumatoid arthritis test for Abbott ...
Proactive Investors UK, UK - Jan 6, 2009
The antibodies may occur in the blood long before the onset of symptoms and the anti-CCP test is superior to rheumatoid factor (RF) regarding diagnostic ...


Read more...


Denosumab Improves BMD in Breast Cancer Patients Taking Aromatase ... - Cance...

5 Jan 2009 at 3:44pm 

Denosumab Improves BMD in Breast Cancer Patients Taking Aromatase ...
Cancer Consultants, ID - Jan 5, 2009
Denosumab is being studied across a range of conditions, including osteoporosis, treatment-induced bone loss, rheumatoid arthritis, bone metastases, ...


Read more...


Elevated Rheumatoid Factor Links

Rheumatoid Arthritis Info
Get facts about rheumatoid arthritis symptoms, treatment, & more.
arthritis-faq.org

Runofnetworkwildcard
See Victoria, Rihanna, Gwyneth and more celebrities who cut their hair shorter and made our hair hall of fame.
ELLE.com

Credit Card Application
Need to apply for a credit card?